Age-related prostate cancer metastases

Urology

Volumn 51, Issue 6, 1998, Pages 985-990

  Herold, D M ^a   Hanlon, A L ^a   Movsas, B ^a   Hanks, G E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; FOLLOW UP; HEALTH CARE COST; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT FAILURE;

ADENOCARCINOMA; AGE DISTRIBUTION; AGE FACTORS; AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 0032100431     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00029-6     Document Type: Article

References (22)

1. Lee W., Hanks G., Schultheiss T., et al. Localized prostate cancer treated by external beam radiotherapy alone serum prostate-specific antigen driven outcome analysis . J Clin Oncol. 13:1995;464-469.
2. Kuban D., El-Mahdi A., Schellhammer P. Prostate specific antigen for pretreatment prediction and post-treatment evaluation of outcome after definitive irradiation. Int J Radiat Oncol Biol Phys. 32:1995;307-316.
3. D'Amico A., Hanks G. Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer. Cancer. 72:1993;2638-2643.
4. Sartor C., Strawderman M., Lin X., et al. Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy. Int J Radiat Oncol Biol Phys. 38:1997;941-947.
5. Hanks G.E., Schultheiss T.E., Hanlon A.L., et al. Optimization of conformal radiation treatment of prostate cancer report of a dose escalation study . Int J Radiat Oncol Biol Phys. 37:1997;543-550.
6. International Commission on Radiation Units and Measurements (ICRU): Prescribing, recording, and reporting photon beam therapy. Proceedings of the International Conference on Radiation Units and Measurements, Washington, DC, 1993. Washington, DC, ICRU Publications, 1993, ICRU Report No. 50.
7. Movsas B., Hanlon A., Tshima T., et al. Analyzing predictive models following definitive radiotherapy for prostate carcinoma. Cancer. 80:1997;1093-1102.
8. Pinover W., Hanlon A., Hanks G. bNED control praying to a false God? Int J Radiat Oncol Biol Phys. 39:1997;218.
9. Kant A., Glover C., Horm J., et al. Does cancer survival differ for older patients. Cancer. 70:1992;2734-2740.
10. Partin A.W., Pound C.R., Clemens Q., et al. Serum PSA after anatomic radical prostatectomy The Johns Hopkins experience after 10 years . Urol Clin North Am. 20:1993;713-725.
11. Freedman G., Hanlon A., Lee W., et al. Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation. Int J Radiat Oncol Biol Phys. 35:1996;243-250.
12. Perez C., Garcia D., Simpson J., et al. Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate. Radiother Oncol. 16:1989;1-21.
13. Zagars G., VonEschenbach A., Ayala A. Prognostic factors in prostate cancer. Cancer. 72:1993;1709-1725.
14. Partin A., Steingberg G., Pitcock R., et al. Use of nuclear morphometry, Gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer. Cancer. 70:1992;161-168.
15. Huben R., Natarajan N., Pontes E., et al. Carcinoma of prostate in men less than fifty years old. Urology. 20:1982;585-588.
16. Berner A., Harvei S., Tretli S., et al. Prostatic carcinoma a multivariate analysis of prognostic factors . Br J Cancer. 69:1994;924-930.
17. Silber I., McGavran M. Adenocarcinoma of the prostate in men less than 56 years old a study of 65 cases . J Urol. 105:1971;283-285.
18. Alexander R., Maguire M., Epstein J., et al. Pathological stage is higher in older men with clinical stage B1 adenocarcinoma of the prostate. J Urol. 141:1989;880-882.
19. Richie J., Catalona W., Ahmann F., et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology. 42:1993;365-374.
20. MacManus M., Hoppe R. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University . J Clin Oncol. 14:1996;1282-1290.
21. Pilepich M., Caplan R., Byhardt R., et al. Phase II trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy report of the radiation therapy oncology group protocol 85-31 . J Clin Oncol. 15:1997;1013-1021.
22. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 337:1997;295-300.